TY  - JOUR
AU  - Perez, Marco
AU  - Garcia-Heredia, Jose Manuel
AU  - Felipe-Abrio, Blanca
AU  - Muñoz-Galvan, Sandra
AU  - Martin-Broto, Javier
AU  - Carnero, Amancio
PY  - 2020
DO  - 10.1038/s41392-020-00246-z
UR  - http://hdl.handle.net/10668/16297
T2  - Signal transduction and targeted therapy
AB  - Sarcomas constitute a rare heterogeneous group of tumors, including a wide variety of histological subtypes. Despite advances in our understanding of the pathophysiology of the disease, first-line sarcoma treatment options are still limited and new...
LA  - en
PB  - Nature Publishing Group
KW  - Cancer models
KW  - Sarcoma
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Histones
KW  - Membrane Proteins
KW  - Prognosis
KW  - Xenograft Model Antitumor Assays
KW  - Adult
KW  - Aged
KW  - Animals
KW  - Biomarkers, Tumor
KW  - Cell Line, Tumor
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Male
KW  - Mice
KW  - Middle Aged
KW  - Neoplasm Proteins
KW  - Phthalazines
KW  - Piperazines
KW  - Sarcoma
TI  - Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment.
TY  - research article
VL  - 5
ER  -